FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca 2+ /calmodulin-mediated signalling pathways in vivo and in vitro.

MLA

Xiao, Yun-Fei, et al. “FKBP12.6 Protects Heart from AngII-Induced Hypertrophy through Inhibiting Ca 2+ /Calmodulin-Mediated Signalling Pathways in Vivo and in Vitro.” Journal of Cellular and Molecular Medicine, vol. 22, no. 7, July 2018, pp. 3638–51. EBSCOhost, https://doi.org/10.1111/jcmm.13645.

APA

Xiao, Y.-F., Zeng, Z.-X., Guan, X.-H., Wang, L.-F., Wang, C.-J., Shi, H., Shou, W., Deng, K.-Y., & Xin, H.-B. (2018). FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca 2+ /calmodulin-mediated signalling pathways in vivo and in vitro. Journal of Cellular and Molecular Medicine, 22(7), 3638–3651. https://doi.org/10.1111/jcmm.13645

Chicago

Xiao, Yun-Fei, Zhi-Xiong Zeng, Xiao-Hui Guan, Ling-Fang Wang, Chan-Juan Wang, Huidong Shi, Weinian Shou, Ke-Yu Deng, and Hong-Bo Xin. 2018. “FKBP12.6 Protects Heart from AngII-Induced Hypertrophy through Inhibiting Ca 2+ /Calmodulin-Mediated Signalling Pathways in Vivo and in Vitro.” Journal of Cellular and Molecular Medicine 22 (7): 3638–51. doi:10.1111/jcmm.13645.